Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

As of 2026-08-12, the Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Last verified: 2026-08-12

Am I eligible for the Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges?

A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

How do I join the Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges?

1. Run the free 1-minute eligibility self-check.
2. If you qualify, register your claim on the platform.
3. Class members typically pay nothing unless money is recovered.

Other active class actions

• Inferior Vena Cava IVC Filter Class Action
• Johnson and Johnson Ovarian Cancer Class Action
• 911 Fees Class Action
• Barrick Pascua-Lama Class Action
• Bernzomatic Gas Torch Defect Class Action
• Canadian Standards Association/Standards Council of Canada Class Actio
• Chevy & Cadillac Defective Transmissions – GM Class Action Canada
• Chrysler Ignition Class Action
• Dodge Chrysler Tire Sensor Defect Class Action
• Eliquis Class Action
• Essure Permanent Birth Control Class Action
• Fiat Chrysler Diesel Emissions Class Action

← Browse all 3702+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.